Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 7,000 | 23,385 | 50,931 | 27,941 | 19,538 |
| Gross Profit | 7,000 | 23,385 | 50,931 | 27,941 | 19,538 |
| Operating Expenses | 333,975 | 157,814 | 113,433 | 78,209 | 54,882 |
| Operating Income | -326,975 | -134,429 | -62,502 | -50,268 | -35,344 |
| Other Income | 52,498 | 21,468 | 3,847 | 506 | 849 |
| Pre-tax Income | -274,477 | -112,961 | -58,655 | -49,762 | -34,495 |
| Net Income Continuous | -274,477 | -112,961 | -58,655 | -49,762 | -34,495 |
| Net Income | $-274,477 | $-112,961 | $-58,655 | $-49,762 | $-34,495 |
| EPS Basic Total Ops | -3.36 | -1.96 | -1.42 | -1.41 | -1.40 |
| EPS Basic Continuous Ops | -3.36 | -1.96 | -1.42 | -1.41 | -1.40 |
| EPS Diluted Total Ops | -3.36 | -1.96 | -1.42 | -1.41 | -1.40 |
| EPS Diluted Continuous Ops | -3.36 | -1.96 | -1.42 | -1.41 | -1.40 |
| EPS Diluted Before Non-Recurring Items | -3.36 | -1.96 | -1.42 | -1.41 | -1.40 |
| EBITDA(a) | $-346,374 | $-141,974 | $-59,682 | $-46,709 | $-33,385 |